Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Comparative, Placebo-controlled, Double-blinded, Phase II Study of the Efficacy of Lenvatinib in Patients With Locally Advanced or Metastatic GIST After Failure of Imatinib and Sunitinib

NCT04193553 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04193553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04193553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Comparative, Placebo-controlled, Double-blinded, Phase II Study of the Efficacy of Lenvatinib in Patients With Locally Advanced or Metastatic GIST After Failure of Imatinib and Sunitinib
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Completed
Start date
January 17, 2020
Completion date
April 26, 2024
Enrollment
77 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

gastro intestinal stromal tumour